ReviewFrontiers in immunology2026

CDK4/6-targeted therapy for gastrointestinal cancers: from resistance mechanisms to immuno-combination strategies guided by biomarkers.

Junhao Cui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.